| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 7 |
| 1 | ACETAMINOPHEN 500MG | 5 |
| 2 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 5 |
| 3 | OMEPRAZOLE MAGNESIUM | 5 |
| 4 | PAIN RELIEVER | 5 |
| 5 | OMEPRAZOLE | 4 |
| 6 | CARBOPLATIN | 3 |
| 7 | LORAZEPAM | 3 |
| 8 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 2 |
| 9 | ADRENALINUM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ISRADIPINE | 1 | 0.0018 |
| 1 | SARGRAMOSTIM | 1 | 0.0006 |
| 2 | DEXMEDETOMIDINE HYDROCHLORIDE | 1 | 0.0003 |
| 3 | PALONOSETRON HYDROCHLORIDE | 1 | 0.0002 |
| 4 | LORLATINIB | 1 | 0.0001 |
| 5 | TESTOSTERONE CYPIONATE | 1 | 0.0001 |
| 6 | HYOSCYAMINE SULFATE | 1 | 0.0001 |
| 7 | NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0000 |
| 8 | DABRAFENIB | 1 | 0.0000 |
| 9 | EXEMESTANE | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 7 |
| 1 | Corticosteroid [EPC] | 5 |
| 2 | Platinum-based Drug [EPC] | 4 |
| 3 | Proton Pump Inhibitor [EPC] | 4 |
| 4 | Benzodiazepine [EPC] | 3 |
| 5 | Alkylating Drug [EPC] | 2 |
| 6 | Catecholamine [EPC] | 2 |
| 7 | Expectorant [EPC] | 2 |
| 8 | Opioid Agonist [EPC] | 2 |
| 9 | alpha-Adrenergic Agonist [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Androgen [EPC] | 1 | 0.0000 |
| 1 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 2 | Estrogen Receptor Antagonist [EPC] | 1 | 0.0000 |
| 3 | Catecholamine [EPC] | 2 | 0.0000 |
| 4 | Platinum-based Drug [EPC] | 4 | 0.0000 |
| 5 | Tetracycline-class Drug [EPC] | 1 | 0.0000 |
| 6 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 9 | Expectorant [EPC] | 2 | 0.0000 |